AUS: (617) 38560661 or 1300 SEIPEL | US: (855) 950-4567 | E-mail: contact@seipelgroup.com

The Australian Patent Office has granted us a second patent on Prorox® due to the uniqueness of the formulation. The patent is for the Prevention or Treatment of Benign Prostatic Hyperplasia (BPH) and Related Disorders. We have multiple bladder and prostate patent families, and Urox is currently patented or patent-pending in 25 countries with numerous global trademarks.